Rchr
J-GLOBAL ID：202201010146477379
Update date: Apr. 19, 2024
Ogawa Takashi
オガワ タカシ | Ogawa Takashi
Affiliation and department：
Papers (57)：
-
Hikaru Kamo, Hirokazu Iwamuro, Ryota Nakamura, Shuko Nojiri, Ayami Okuzumi, Takashi Ogawa, Asuka Nakajima, Nobutaka Hattori, Yasushi Shimo. Antagonism of metabotropic glutamate receptor type 5 prevents levodopa-induced dyskinesia development in a male rat model of Parkinson's disease: Electrophysiological evidence. Journal of neuroscience research. 2024. 102. 3. e25302
-
Haruka Takeshige-Amano, Taku Hatano, Koji Kamagata, Christina Andica, Takashi Ogawa, Atsuhiko Shindo, Wataru Uchida, Wataru Sako, Shinji Saiki, Yasushi Shimo, et al. Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson's disease. Journal of the Neurological Sciences. 2024. 457
-
Haruka Takeshige-Amano, Taku Hatano, Koji Kamagata, Christina Andica, Takashi Ogawa, Atsuhiko Shindo, Wataru Uchida, Wataru Sako, Shinji Saiki, Yasushi Shimo, et al. Free-water diffusion magnetic resonance imaging under selegiline treatment in Parkinson's disease. Journal of the neurological sciences. 2024. 457. 122883-122883
-
Taku Hatano, Genko Oyama, Yasushi Shimo, Kotaro Ogaki, Noriko Nishikawa, Ryota Nakamura, Taiji Tsunemi, Takashi Ogawa, Hiroto Eguchi, Kensuke Daida, et al. Efficacy and Safety of Elobixibat in Parkinson's Disease with Chronic Constipation: CONST-PD Study. Movement disorders clinical practice. 2024
-
Wataru Sako, Akimitsu Suda, Daisuke Taniguchi, Koji Kamagata, Atsuhiko Shindo, Takashi Ogawa, Yutaka Oji, Noriko Nishikawa, Taku Hatano, Shigeki Aoki, et al. Midbrain atrophy in pathologically diagnosed Lewy body disease and clinically diagnosed Parkinson's disease. Journal of the neurological sciences. 2023. 454. 120821-120821
ｍore...
MISC (9)：
-
波田野琢, 小川崇, 竹重遥香, 奥住文美, 服部信孝. Development of biomarkers of synucleinopathy. 神経治療学(Web). 2023. 40. 3
-
波田野琢, 奥住文美, 小川崇, 服部信孝. シヌクレイノパチーの新規バイオマーカーの開発. 神経治療学(Web). 2022. 39. 6
-
佐光亘, 谷口大祐, 須田晃充, 進藤淳彦, 小川崇, 王子悠, 波田野琢, 鎌形康司, 青木茂樹, 服部信孝. MRI上の中脳・橋サイズ測定が病理診断確定PSP・MSAを鑑別しうるか. 日本神経学会学術大会プログラム・抄録集. 2022. 63rd
-
長谷川春菜, 佐光亘, 波田野琢, 鎌形康司, 小川崇, 内田航, 進藤淳彦, 竹重遥香, 加茂晃, 大山彦光, et al. 脳深部刺激療法前後におけるレボドパ内服量減少に関わる白質領域の同定. 日本神経学会学術大会プログラム・抄録集. 2022. 63rd
-
津山 恒, 小川 崇, 波田野 琢, 竹重 遥香, Andica Christina, 齋藤 麻美, 鎌形 康司, 濃沼 崇博, 中村 亮太, 岩室 宏一, et al. レボドパ誘発性ジスキネジアを呈するパーキンソン病ではVTAは保たれる. 臨床神経学. 2020. 60. Suppl. S446-S446
ｍore...
Awards (3)：
- 2022/05 - The Japanese Society of internal Medicine Award for excellence
- 2019/05 - International Parkinson and Movement Disorder Society 2019 MDS International Congress Travel Grant Award
- 2018/07 - Movement Disorders Society of Japan Poster (Basic section): Award for excellence Identification of putative serum biomarkers for PARK2 by Metabolome analysis
Return to Previous Page
